Guidant buys into developer of stroke device:
This article was originally published in Clinica
Executive Summary
Guidant has bought an equity stake of an undisclosed size in Neuroperfusion. The investment was part of a round of venture capital financing raised by Neuroperfusion. Based in Irvine, California, the company is developing a catheter-based approach to treating victims of acute ischaemic stroke. With its technology, oxygenated blood sourced from an artery in the leg is pumped in a reverse direction into veins in the brain. The reversal of flow is intended to support the brain tissue until either the clot resolves or another interventional device is introduced to unblock the artery.